Sumitomo Mitsui Trust Group Inc. Reduces Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui Trust Group Inc. lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 10.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 275,630 shares of the company’s stock after selling 33,053 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.22% of Henry Schein worth $20,093,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after purchasing an additional 260,537 shares during the period. TIAA Trust National Association increased its holdings in shares of Henry Schein by 4.9% during the 1st quarter. TIAA Trust National Association now owns 5,440 shares of the company’s stock worth $411,000 after buying an additional 252 shares during the last quarter. Covestor Ltd increased its holdings in Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after purchasing an additional 171 shares in the last quarter. UniSuper Management Pty Ltd increased its holdings in Henry Schein by 611.8% in the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock valued at $1,034,000 after purchasing an additional 11,771 shares in the last quarter. Finally, MQS Management LLC purchased a new position in Henry Schein in the 1st quarter valued at about $399,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 22.65 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Stock Up 3.3 %

Shares of Henry Schein stock opened at $68.76 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The stock has a market capitalization of $8.57 billion, a price-to-earnings ratio of 28.30, a P/E/G ratio of 1.97 and a beta of 0.87. The company’s 50 day moving average price is $70.30 and its 200-day moving average price is $69.57.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.32 earnings per share. Equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.